Dr. Wang's project
We are proud to announce the award of a grant of 81,400 euros for a pioneering research initiative led by Dr. Haicui Wang from the Department of Human and Animal Cell Lines of the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH. The goal is to advance potential treatments for CNM by developing multiple muscle models (MTM1, DNM2, RYR1, BIN1), each engineered with a specific CNM mutation, and then applying CRISPR technology to treat them.